Iconic Therapeutics
South San Francisco, US · Delaware corporation · 2 known investors
Find your way into Iconic Therapeutics
444 people in our graph share verified history with the Iconic Therapeutics team — schools, employers, funds. One of them is your warm intro.
Jennifer Zimmermanunlockedknows William Greene · together at Wesleyan University (overlapped)
×3knows the team · via Yale University
×4knows the team · via Wesleyan University
knows the team · via University of California, San Francisco
knows the team · via Mpmcapital
×2knows the team · via MPM BioImpact
Founders & leadership
KD
Kirk DornbushExecutive
WG
William GreeneinExecutiveWilliam Greene holds an M.D. and has held leadership roles spanning biotechnology research, clinical program management, global venture capital investment, and board positions at life sciences firms; he has served as CEO of two biotech startups from discovery through fundraising and exits.
Board
JK
Johan KordelBoard director
BR
Bruce RobertsonBoard director
TF
PH
Peter HirthBoard director
JS
Jon SoderstromBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$79M disclosed across 4 rounds · 2014–2019
▶$13MraisedApr 2019 · 37 investors · BiotechnologyRule 506(b)
▶$13MraisedApr 2019 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce CohenDirector
- Peter HirthDirector
- Bruce RobertsonDirector
- Julia GregoryDirector
- Todd FoleyDirector
- William GreeneExecutive Officer, Director
- Kirk DornbushDirector
- Offering amount
- $16.3M
- Amount sold
- $13M
- Proceeds to insiders
- $500K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedJun 2018 · 36 investors · BiotechnologyRule 506(b)
▶$4.1MraisedJun 2018 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Julia GregoryDirector
- Kirk DornbushDirector
- Peter HirthDirector
- Bruce RobertsonDirector
- William GreeneExecutive Officer, Director
- Todd FoleyDirector
- Offering amount
- $10.9M
- Amount sold
- $4.1M
- Proceeds to insiders
- $500K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$48.6MraisedNov 2016 · 11 investors · BiotechnologyRule 506(b)
▶$48.6MraisedNov 2016 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johan KordelDirector
- Bruce RobertsonDirector
- Todd FoleyDirector
- Kirk DornbushExecutive Officer, Director
- Peter HirthDirector
- William GreeneExecutive Officer, Director
- Offering amount
- $48.6M
- Amount sold
- $48.6M
- Proceeds to insiders
- $500K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.3MraisedApr 2014 · 40 investors · BiotechnologyRule 506(b)
▶$13.3MraisedApr 2014 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kirk DornbushExecutive Officer, Director
- Todd FoleyDirector
- Bruce RobertsonDirector
- Johan KordelDirector
- William GreeneExecutive Officer, Director
- Jon SoderstromDirector
- Offering amount
- $24.3M
- Amount sold
- $13.3M
- Proceeds to insiders
- $216K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Iconic Therapeutics's investors?
- Iconic Therapeutics's investors include OUP (Osage University Partners), MPM BioImpact.
- How much funding has Iconic Therapeutics raised?
- Iconic Therapeutics has disclosed $79M raised across 4 rounds.
- Where is Iconic Therapeutics headquartered?
- Iconic Therapeutics is headquartered in South San Francisco, US.